ArticleInternational journal of molecular sciences2025

Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor.

Bojan Jevtić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.